Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04989283
Title Testing the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy Treatment During Radiation Therapy for Superior Sulcus Non-small Cell Lung Cancer
Recruitment Withdrawn
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.